Clinical trial

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

NCT00002823

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record etoposide Normalized identity: etoposideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record vinblastine sulfate Normalized identity: vinblastine sulfateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention vindesine Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record vinorelbine tartrate Normalized identity: vinorelbine tartrateView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1995-02-01

PhasePHASE3

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

etoposideDRUG · verified · RxNorm: etoposide

vinblastine sulfateDRUG · verified · RxNorm: vinblastine sulfate

vindesineDRUG

vinorelbine tartrateDRUG · verified · RxNorm: vinorelbine tartrate

radiation therapyRADIATION

Sponsors & collaborators

Gustave Roussy, Cancer Campus, Grand Parislead sponsor

Mapped research locations

ParisFrance4 AthensGreece4 WroclawPoland2 MelbourneVictoria, Australia2 CaenFrance2 ZurichSwitzerland2 AngersFrance2 RomeItaly2 JohannesburgSouth Africa2 BogotáColombia2 BostonMassachusetts, United States1 BarcelonaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00002823 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.